Medcura, INC
At a glance
Employees20-99
In business sinceNot reported
HeadquartersRiverdale, MD
US patents4
SAM.gov UEIHFL9S8BZK9N5
CAGE code5H1B0
Incorporated inDE
- bleeding
- biopolymer technologies
- biomaterials
- mucoadhesion
- surgeons
- payers
- military
- spine surgery
- cardiac surgery
- minimally invasive surgery
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2022–2025, 4 of them in the five years to SEP 2025.
Pharmaceuticals 4
- System and method to reduce tissue ororgan adhesionUS 12,403,157 · granted SEP 2, 2025
- Hydrophobically-modified biopolymer materialsUS 12,201,742 · granted JAN 21, 2025
- Hydrophobically modified chitosan compositionsUS 11,787,922 · granted OCT 17, 2023
- Hydrophobically modified chitosan compositionsUS 11,274,194 · granted MAR 15, 2022
Granted to Medcura, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Medcura, INC | Riverdale | MD | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.